Semantic similarity in biomedical ontologies.

Pesquita C, Faria D, Falcão AO, Lord P, Couto FM. · 2009

Read Semantic similarity in biomedical ontologies. by Pesquita C, Faria D, Falcão AO, Lord P, Couto FM. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2712090.txt.

Introduction

Pesquita and co-authors reviewed in 2009 semantic similarity, a way to compare living things by the meaning of their labels in a biomedical ontology. An ontology is a formal schema that names traits and how they relate. When genes or diseases share that schema, their label sets can be scored for how close in meaning they are.

Their review sorts measures into node-based and edge-based forms, and into pairwise and groupwise forms. It also surveys tests that compare the measures and the software that runs them. Uses include checking gene groups, gene activity studies, and hunting for disease genes. The authors expect such measures to grow as central as sequence matching already is.

Catalog record

CREATORPesquita C, Faria D, Falcão AO, Lord P, Couto FM.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE68 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2712090

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Semantic Similarity in Biomedical Ontologies By Catia Pesquita, Daniel Faria, André O Falcão, Phillip Lord, Francisco M Couto, Philip E Bourne Published in: PLoS Computational Biology DOI: 10.1371/journal.pcbi.1000443 ABSTRACT Abstract In recent years, ontologies have become a mainstream topic in biomedical research. When biological entities are described using a common schema, such as an ontology, they can be compared by means of their annotations. This type of comparison is called semantic similarity, since it assesses the degree of relatedness between two entities by the similarity in meaning of their annotations. The application of semantic similarity to biomedical ontologies is recent; nevertheless, several studies have been published in the last few years describing and evaluating diverse approaches. Semantic similarity has become a valuable tool for validating the results drawn from biomedical studies such as gene clustering, gene expression data analysis, prediction and validation of molecular interactions, and disease gene prioritization. We review semantic similarity measures applied to biomedical ontologies and propose their classification according to the strategies they employ: node-based versus edge-based and pairwise versus groupwise. We also present comparative assessment studies and discuss the implications of their results. We survey the existing implementations of semantic similarity measures, and we describe examples of applications to biomedical research. This will clarify how biomedical researchers can benefit from semantic similarity measures and help them choose the approach most suitable for their studies. Biomedical ontologies are evolving toward increased coverage, formality, and integration, and their use for annotation is increasingly becoming a focus of both effort by biomedical experts and application of automated annotation procedures to create corpora of higher quality and completeness than are currently available. Given that semantic similarity measures are directly dependent on these evolutions, we can expect to see them gaining more relevance and even becoming as essential as sequence similarity is today in biomedical research. INTRODUCTION Comparison and classification have been central pillars of biology since Linnaeus proposed his taxonomy and Darwin observed the mockingbirds on the Galapagos Islands. Like most scientific knowledge, biological laws and models are derived from comparing entities (such as genes, cells, organisms, populations, species) and finding their similarities and differences. However, biology is unlike other sciences in that its knowledge can seldom be reduced to mathematical form. Thus, biologists either record their knowledge in natural language—for example, in scientific publications—or they must seek other forms of representation to organize it, such as classification schemes. When new entities arise, biologists approach them by comparing them to known entities and making inferences according to their degree of similarity. Comparing entities is not always trivial. For instance, while the sequences or structures of two gene products can be compared directly (through alignment algorithms), the same is not true of their functional aspects. The difference is that sequences and structures have an objective representation and measurable properties, whereas functional aspects have neither. This does not mean that it is impossible to compare functional aspects, but that to be compared they must be expressed in a common and objective form. The advent of automated sequencing has had deep repercussions on knowledge representation in biology. As experimental methods shift in scope from the gene level to the genomic level, computational analysis is proving essential in handling the increasing amount of data. Thus it has become crucial to adopt common and objective knowledge representations to help knowledge sharing and computer reasoning. This need led to the development of ontologies for goals such as annotating gene products (Gene Ontology), annotating sequences (Sequence Ontology), and annotating experimental assays (Microarray and Gene Expression Data Ontology). The adoption of ontologies for annotation provides a means to compare entities on aspects that would otherwise not be comparable. For instance, if two gene products are annotated within the same schema, we can compare them by comparing the terms with which they are annotated. While this comparison is often done implicitly (for instance, by finding the common terms in a set of interacting gene products), it is possible to do an explicit comparison with semantic similarity measures. Within the context of this article, we define a semantic similarity measure as a function that, given two ontology terms or two sets of terms annotating two entities, returns a numerical value reflecting the closeness in meaning between them. The Gene Ontology (GO) [1] is the main focus of investigation of semantic similarity in molecular biology, not only because it is the ontology most widely adopted by the life sciences community, but also because comparing gene products at the functional level is crucial for a variety of applications. Semantic similarity applied to the GO annotations of gene products provides a measure of their functional similarity. From this point forward, we will use the term “functional similarity” when referring to the similarity between two gene products given by the semantic similarity between the sets of GO terms with which they are annotated. As such, the semantic similarity measures and the studies reviewed in this article are presented in the context of GO, notwithstanding the fact that they are applicable to other biological ontologies. GO provides a schema for representing gene product function in the cellular context. Figure 1 shows how GO is structured as three independent directed acyclic graphs (DAGs) that correspond to orthogonal categories of gene product function: molecular function, biological process, and cellular component. The nodes in the graph represent terms that describe components of gene product function. GO links the terms to each other by relationships, most commonly of the types ‘is a’ and ‘part of’, the former expressing a simple class–subclass relationship and the latter expressing a part–whole relationship. Gene products that are described by GO terms are said to be annotated with them, either directly or through inheritance, since annotation to a given term implies annotation to all of its ancestors (true path rule). The Gene Ontology Consortium is responsible for developing and maintaining GO terms, their relationships, and their annotations to genes and gene products of the collaborating databases. Moreover, GO Consortium is also responsible for developing tools that support the creation, maintenance, and use of all this information. [Figure: Section of the GO graph showing the three aspects (molecular function, biological process, and cellular component) and some of their descendant terms.The fact that GO is a DAG rather than a tree is illustrated by the term “transcription factor activity” which has two parents. An example of a part of relationship is also shown between the terms cell part and cell.] CLASSIFICATION OF SEMANTIC SIMILARITY MEASURES Several approaches are available to quantify semantic similarity between terms or annotated entities in an ontology represented as a DAG such as GO. This article distinguishes these approaches in the following way: - Scope: Which entities they intend to compare, that is, GO terms versus gene products; - Data source: Which components of the ontology they use, i.e., edges versus nodes; - Metric: How they quantify and combine the information stored on those components. Comparing Terms There are essentially two types of approaches for comparing terms in a graph-structured ontology such as GO: edge-based, which use the edges and their types as the data source; and node-based, in which the main data sources are the nodes and their properties. We

Read the complete text